🔎 Trials Near Me

Acasă › Crize convulsive › Texas

Studii clinice pentru Crize convulsive în Texas

14 studii pentru Crize convulsive caută participanți în Texas.

Orașe în Texas

Text oficial al studiului (în engleză)

An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome

  • Children's Health Specialty Center, Dallas
  • UTHealth Houston, Houston
În curs de recrutareFaza 3
Vârste de la 2 la 55 · Toate sexele · Actualizat 2 oct. 2026 · NCT05066217

A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures

  • Child Neurology & Consultants of Austin, Austin
  • ANESC Research, El Paso
În curs de recrutareFaza 1
Vârste de la 12 la 75 · Toate sexele · Actualizat 2 oct. 2026 · NCT07233239

RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures

  • Advanced Neurology Epilepsy and Sleep Center/ANESC Research, El Paso
  • Stryde Research, Frisco
  • UT Health Houston, Houston
În curs de recrutareFaza 2
Vârste de la 18 la 70 · Toate sexele · Actualizat 1 oct. 2026 · NCT06798896

Prospective Natural History Study of POLG Disease

  • Baylor Hospital, Dallas
  • UTHealth Houston, Houston
În curs de recrutareStudiu observațional
Toate vârstele · Toate sexele · Actualizat 15 sept. 2026 · NCT07775872

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

  • Child Neurology Consultants of Austin, Austin
În curs de recrutareFaza 3
Vârste de 2 ani și peste · Toate sexele · Actualizat 15 sept. 2026 · NCT04462770

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures

  • Baylor College of Medicine, Houston
  • University of Texas Health Science Center in Houston, Houston
În curs de recrutareFaza 3
Vârste de la 18 la 75 · Toate sexele · Actualizat 2 sept. 2026 · NCT07594119

Mapping of Human Cognition

  • The University of Texas Health Science Center at Houston, Houston
În curs de recrutare
Vârste de la 18 la 75 · Toate sexele · Actualizat 14 iul. 2026 · NCT05989893

Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

  • UT Southwestern Medical Center, Dallas
  • UTHealth Houston, Houston
În curs de recrutareFaza 3
Vârste de la 18 la 75 · Toate sexele · Actualizat 9 iun. 2026 · NCT05135091

A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)

  • Austin Epilepsy Care Center, Austin
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 14 mai 2026 · NCT05716100

A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures

  • Baylor College of Medicine, Houston
În curs de recrutareFaza 2
Vârste de la 18 la 70 · Toate sexele · Actualizat 23 ian. 2026 · NCT07219407

Pharmacological Modulation of Brain Oscillations in Memory Processing

  • University of Texas Southwestern Medical Center, Dallas
În curs de recrutareFaza 1 timpurieVoluntari sănătoși bineveniți
Vârste de la 18 la 55 · Toate sexele · Actualizat 3 oct. 2025 · NCT05594017

Pediatric Dose Optimization for Seizures in Emergency Medical Services

  • University of Texas Southwestern, Dallas
  • Baylor College of Medicine, Houston
În curs de recrutareFaza 3
6 Months – 13 Years · Toate sexele · Actualizat 30 sept. 2025 · NCT05121324

An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures

  • Praxis Research Site, Round Rock
  • Praxis Research Site, Seabrook
În curs de recrutareFaza 2
Vârste de la 18 la 75 · Toate sexele · Actualizat 3 apr. 2025 · NCT06908356

Epilepsy Learning Healthcare System (ELHS)

  • UT Southwestern Children's Dallas, Dallas
În curs de recrutareStudiu observațional
Toate vârstele · Toate sexele · Actualizat 30 aug. 2024 · NCT06265103

Sursă: ClinicalTrials.gov, date preluate la 3 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.